SCHEMBL6980125

SCHEMBL6980125

O=C(NC(=O)C(c1ccccc1)c1ccccc1)C1CCCN1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.51
CYP2D6 P10635 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2C19 P33261 1/20 0.51
CTSC P53634 2/20 0.49
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC10 Q969S8 1/20 0.47
HDAC11 Q96DB2 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
HDAC9 Q9UKV0 1/20 0.47
HDAC5 Q9UQL6 1/20 0.47
CYP2C9 P11712 1/20 0.47
TSHR P16473 1/20 0.47
HTR2C P28335 1/20 0.44
HTR2B P41595 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13570515 0.89 CYP3A4 (0.51) CYP3A4CYP2D6CYP1A2CYP2C19CTSC
SCHEMBL13570392 0.83 CYP3A4 (0.49) CYP3A4CYP2D6CYP1A2CYP2C19CTSC
SCHEMBL2176484 0.83 CYP3A4 (0.55) CYP3A4CYP2D6CYP1A2CYP2C19CTSC
SCHEMBL27777396 0.82 HDAC3 (0.51) CYP3A4CYP2D6CYP1A2CYP2C19CTSC
SCHEMBL13570579 0.82 CYP3A4 (0.51) CYP3A4CYP2D6CYP1A2CYP2C19CTSC
SCHEMBL5634616 0.82 HDAC3 (0.46) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL24057819 0.79 LMNA (0.60) CYP3A4CYP2D6CYP1A2CYP2C19CTSC
SCHEMBL7305357 0.79 LMNA (0.60) CYP3A4CYP2D6CYP1A2CYP2C19CTSC
SCHEMBL24056571 0.79 LMNA (0.60) CYP3A4CYP2D6CYP1A2CYP2C19CTSC
SCHEMBL8397188 0.78 CTSC (0.49) CYP3A4CYP2D6CYP1A2CYP2C19CTSC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1268418-A1 PHARMACEUTICALLY ACTIVE PYRROLIDINE DERIVATIVES AS BAX INHIBITORS Applied Research Systems ARS Holding N.V. (AN) 2003-01-02 EP disclosed
WO-2001074769-A1 PHARMACEUTICALLY ACTIVE PYRROLIDINE DERIVATIVES AS BAX INHIBITORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2001-10-11 WO disclosed